Literature DB >> 26611475

Time-dependent effects of clinical predictors in unrelated hematopoietic stem cell transplantation.

Daniel Fuerst1, Carlheinz Mueller2, Dietrich W Beelen3, Christine Neuchel4, Chrysanthi Tsamadou4, Hubert Schrezenmeier4, Joannis Mytilineos5.   

Abstract

Hematopoietic stem cell transplantation is a multifactorial process. Some of the predictors exhibit time-dependent effects. We present a systematic analysis and description of selected clinical predictors influencing outcome in a time-dependent manner based on an analysis of registry data from the German Registry for Stem Cell Transplantation. A total of 14,951 patients with acute myeloid leukemia, acute lymphocytic leukemia, myelodysplastic syndrome and non-Hodgkin lymphoma transplanted with peripheral blood stem cells or bone marrow grafts were included. Multivariate Cox regression models were tested for time-dependent effects within each diagnosis group. Predictors not satisfying the proportional hazards assumption were modeled in a time-dependent manner, extending the Cox regression models. Similar patterns occurred in all diagnosis groups. Patients with a poor Karnofsky performance score (<80) had a high risk for early mortality until day 139 following transplantation (HR 2.42, CI: 2.19-2.68; P<0.001) compared to patients with a good Karnofsky performance score (80-100). Afterwards the risk reduced to HR 1.43, CI: 1.25-1.63; P<0.001. A lower mortality risk was found for patients after conditioning treatment with reduced intensity until day 120 post transplant (HR: 0.81 CI: 0.75-0.88; P<0.001). After this, a slightly higher risk could be shown for these patients. Similarly, patients who had received a PBSC graft exhibited a significantly lower mortality risk until day 388 post transplantation (HR 0.79, CI: 0.73-0.85; P<0.001), reversing to a significantly higher risk afterwards (HR 1.23, CI: 1.08-1.40; P=0.002). Integrating time dependency in regression models allows a more accurate description and quantification of clinical predictors to be made, which may help in risk assessment and patient counseling. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26611475      PMCID: PMC4938331          DOI: 10.3324/haematol.2015.130401

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  27 in total

1.  Extensions and applications of the Cox-Aalen survival model.

Authors:  Thomas H Scheike; Mei-Jie Zhang
Journal:  Biometrics       Date:  2003-12       Impact factor: 2.571

2.  A perspective on the selection of unrelated donors and cord blood units for transplantation.

Authors:  Stephen R Spellman; Mary Eapen; Brent R Logan; Carlheinz Mueller; Pablo Rubinstein; Michelle I Setterholm; Ann E Woolfrey; Mary M Horowitz; Dennis L Confer; Carolyn K Hurley
Journal:  Blood       Date:  2012-05-17       Impact factor: 22.113

Review 3.  Flexible survival regression modelling.

Authors:  Giuliana Cortese; Thomas H Scheike; Torben Martinussen
Journal:  Stat Methods Med Res       Date:  2009-07-16       Impact factor: 3.021

4.  Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission.

Authors:  Martin S Tallman; Gordon W Dewald; Sharavi Gandham; Brent R Logan; Armand Keating; Hillard M Lazarus; Mark R Litzow; Jayesh Mehta; Tanya Pedersen; Waleska S Pérez; Jacob M Rowe; Meir Wetzler; Daniel J Weisdorf
Journal:  Blood       Date:  2007-03-20       Impact factor: 22.113

5.  Marrow versus blood-derived stem cell grafts for allogeneic transplantation from unrelated donors in patients with active myeloid leukemia or myelodysplasia.

Authors:  Hartmut Bertz; Alexandros Spyridonidis; Gabriele Ihorst; Monika Engelhardt; Carsten Grüllich; Ralph Wäsch; Reinhard Marks; Jürgen Finke
Journal:  Biol Blood Marrow Transplant       Date:  2011-11-20       Impact factor: 5.742

Review 6.  Have we improved in preventing and treating acute graft-versus-host disease?

Authors:  Lia Perez; Claudio Anasetti; Joseph Pidala
Journal:  Curr Opin Hematol       Date:  2011-11       Impact factor: 3.284

7.  Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).

Authors:  R E Champlin; N Schmitz; M M Horowitz; B Chapuis; R Chopra; J J Cornelissen; R P Gale; J M Goldman; F R Loberiza; B Hertenstein; J P Klein; E Montserrat; M J Zhang; O Ringdén; S C Tomany; P A Rowlings; M E Van Hoef; A Gratwohl
Journal:  Blood       Date:  2000-06-15       Impact factor: 22.113

Review 8.  Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults - a systematic review and meta-analysis.

Authors:  Udo Holtick; Melanie Albrecht; Jens M Chemnitz; Sebastian Theurich; Alexander Shimabukuro-Vornhagen; Nicole Skoetz; Christof Scheid; Michael von Bergwelt-Baildon
Journal:  Crit Rev Oncol Hematol       Date:  2014-12-18       Impact factor: 6.312

9.  High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis.

Authors:  Daniel Fürst; Carlheinz Müller; Vladan Vucinic; Donald Bunjes; Wolfgang Herr; Martin Gramatzki; Rainer Schwerdtfeger; Renate Arnold; Hermann Einsele; Gerald Wulf; Michael Pfreundschuh; Bertram Glass; Hubert Schrezenmeier; Klaus Schwarz; Joannis Mytilineos
Journal:  Blood       Date:  2013-09-17       Impact factor: 22.113

10.  High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

Authors:  Stephanie J Lee; John Klein; Michael Haagenson; Lee Ann Baxter-Lowe; Dennis L Confer; Mary Eapen; Marcelo Fernandez-Vina; Neal Flomenberg; Mary Horowitz; Carolyn K Hurley; Harriet Noreen; Machteld Oudshoorn; Effie Petersdorf; Michelle Setterholm; Stephen Spellman; Daniel Weisdorf; Thomas M Williams; Claudio Anasetti
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

View more
  3 in total

1.  Increased age-associated mortality risk in HLA-mismatched hematopoietic stem cell transplantation.

Authors:  Daniel Fürst; Dietger Niederwieser; Donald Bunjes; Eva M Wagner; Martin Gramatzki; Gerald Wulf; Carlheinz R Müller; Christine Neuchel; Chrysanthi Tsamadou; Hubert Schrezenmeier; Joannis Mytilineos
Journal:  Haematologica       Date:  2017-01-05       Impact factor: 9.941

2.  Competing-risk outcomes after hematopoietic stem cell transplantation from the perspective of time-dependent effects.

Authors:  Daniel Fuerst; Sandra Frank; Carlheinz Mueller; Dietrich W Beelen; Johannes Schetelig; Dietger Niederwieser; Jürgen Finke; Donald Bunjes; Nicolaus Kröger; Christine Neuchel; Chrysanthi Tsamadou; Hubert Schrezenmeier; Jan Beyersmann; Joannis Mytilineos
Journal:  Haematologica       Date:  2018-06-07       Impact factor: 9.941

3.  The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis.

Authors:  Daphne Mytilineos; Chrysanthi Tsamadou; Christine Neuchel; Uwe Platzbecker; Donald Bunjes; Natalie Schub; Eva Wagner-Drouet; Gerald Wulf; Nicolaus Kröger; Niels Murawski; Hermann Einsele; Kerstin Schaefer-Eckart; Sebastian Freitag; Jochen Casper; Martin Kaufmann; Mareike Dürholt; Bernd Hertenstein; Stefan Klein; Mark Ringhoffer; Carlheinz R Mueller; Sandra Frank; Hubert Schrezenmeier; Daniel Fuerst; Joannis Mytilineos
Journal:  Front Immunol       Date:  2021-01-25       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.